Biolimus-eluting stent

DEVICE3 trials

Sponsors

Dr Peter Barlis, Takeshi Morimoto, Yonsei University

Conditions

Coronary Artery DiseaseCoronary Heart Disease

Phase 3

Optical Coherence Tomography Assessment of Intimal Tissue and Malapposition

Dr Peter BarlisCoronary Heart Disease

Start: 2010-10-31End: 2014-12-31Target: 80Updated: 2014-08-05

Phase 4

NOBORI Biolimus-Eluting Versus XIENCE/PROMUS Everolimus-eluting Stent Trial

CompletedNCT01303640

Takeshi MorimotoCoronary Artery Disease

Start: 2011-05-31End: 2015-10-31Updated: 2015-12-10

Unknown Phase

BES, EES, and ZES-R in Real World Practice

TerminatedNCT01397175

Yonsei UniversityCoronary Artery Disease

Start: 2013-01-16End: 2019-01-01Updated: 2019-07-09

Related Papers

Randomized Comparison of Everolimus- and Zotarolimus-Eluting Coronary Stents With Biolimus-Eluting Stents in All-Comer Patients

Circulation Cardiovascular Interventions2020-03-019 citations

Mortality impact of post-discharge myocardial infarction size after percutaneous coronary intervention: a patient-level pooled analysis from the 4 large-scale Japanese studies.

2018-03-052 citations

Final 3-Year Outcome of a Randomized Trial Comparing Second-Generation Drug-Eluting Stents Using Either Biodegradable Polymer or Durable Polymer

Circulation Cardiovascular Interventions2015-10-0162 citations